1. Zepzelca (lurbinectedin) [prescribing information]. Palo Alto, CA: Jazz Pharmaceuticals; 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213702s004lbl.pdf.
2. Questions and Answers on FDA's Adverse Event Reporting System (FAERS). Available at: https://www.fda.gov/drugs/surveillance/questions-and-answers-fdas-adverse-event-reporting-system-faers. Accessed: May 6, 2022.
3. MedDRA. Introductory Guide: MedDRA version 24.0. Available at: https://www.meddra.org/how-to-use/support-documentation/english. Accessed: May 6, 2022.
4. Tumour lysis syndrome: new therapeutic strategies and classification;Cairo;Br J Haematol,2004
5. The Uppsala Monitoring Centre. The use of the WHO-UMC system for standardised case causality assessment. Available at: https://who-umc.org/media/164200/who-umc-causality-assessment_new-logo.pdf. Accessed: 13 April, 2022.